Uncategorized
Specialist: Original AREDS formulation still best option for non-smokers
LISBON, Portugal — Because there are no safety issues in non-smokers exposed to beta-carotene, there is no reason why these patients should be switched to the AREDS2 formulation from the original AREDS formulation, according to one speaker at the Controversies in Ophthalmology meeting. In response to studies reporting an association between beta-carotene and increased risk of mortality and lung cancer, AREDS participants who were current smokers were reassigned to a formulation that did not contain beta-carotene. “At the conclusion of the AREDS, no increase in mortality or lung cancer was (Read more...)